Stryker Logo

What’s your
oral care protocol?

Oral care can significantly impact the risk factors for pneumonia in ventilated and non-ventilated patients.

Free 1-week trial

Pneumonia is the #1
hospital-acquired infection1

Patients shouldn’t have to worry about getting sicker during their hospital stay. But the risk of pneumonia is real—and not just for ventilated, elderly, or ICU patients.

Did you know:
  • Pneumonia is the most common type of infection and accounts for 25% of all hospital-acquired infections (HAIs).1
  • NV-HAP has a mortality rate of 16%.2
  • In a multistate prevalence study, 65% of hospital-acquired pneumonia (HAP) was non-ventilator HAP (NV-HAP).1

Improving oral care is easy and can significantly impact the risk factors for pneumonia.3

Did you know:
  • Within 48 hours of admission, the normal oral flora changes to include respiratory pathogens not normally found in healthy individuals.4
  • Every 4-6 hours 20 billion bacteria duplicate in the oral cavity.4

Current guidelines for prevention of NV-HAP:3

The American Dental Association-approved protocol calls for the use of evidence-based oral care in the acute care setting.

Routine oral care following an evidence-based protocol is a fundamental part of patient care to reduce NV-HAP risk related to oropharyngeal colonization.

Oral care with the right products and educational support addresses the most common modifiable risk factor for pneumonia and has the potential to improve healthcare quality and make healthcare safer for patients.

Supplies should be easily accessible in all hospital units for use by nurses and patients:

Soft-bristled toothbrush

Toothpaste with sodium bicarbonate

Alcohol-free antiseptic mouth rinse

Nonpetroleum-based moisturizer

The American Dental Association-approved protocol calls for the use of evidence-based oral care in the acute care setting.

Routine oral care following an evidence-based protocol is a fundamental part of patient care to reduce NV-HAP risk related to oropharyngeal colonization.

Oral care with the right products and educational support addresses the most common modifiable risk factor for pneumonia and has the potential to improve healthcare quality and make healthcare safer for patients.

Supplies should be easily accessible in all hospital units for use by nurses and patients:

Soft-bristled toothbrush

Toothpaste with sodium bicarbonate

Alcohol-free antiseptic mouth rinse

Nonpetroleum-based moisturizer

Sage Self Oral Care can help you reduce the risk of pneumonia

All-in-one, single use system provides thorough oral care.

• Easy for you and your patients to use.
• Can minimize direct contact with the patient.
• Can remain at bedside and doesn’t require nurse assistance to use.
• Assembled in the USA from foreign and domestic components.

#OralCareForAll means providing the necessary products and support for your ventilated and non-ventilated patients to help perform appropriate oral care and improve outcomes.

Please complete the form and a sales rep will contact you

  • Pre- and post-trial assessments are required to receive 1-week of free product.
  • By submitting your information, you are consenting to being contacted by a sales representative.

References: 1. Data on file. Sage Products, LLC. Chlorhexidine gluconate concentration calculation summary. Gandhi M. April 3, 2020. 2. Third party lab data on file – in vitro testing. 3. 2019 CDC Drug-Resistant Candida Auris Fact Sheet. Part of the Antibiotic Resistance Threats Report. Available online at: https://www.cdc.gov/drugresistance/pdf/threats-report/candida-auris-508.pdf Accessed April 3, 2020. 4.Sung CT, Grigsby P, Lee C, Jacob SE, Benzalkonium Chloride Update, The Dermatologist, Available at: https://www.the-dermatologist.com/article/benzalkonium-chlorideupdate. Accessed January 30, 2019. 5. Isaac, J. and Scheinmann PL. Benzalkonium chloride: A skin irritant and sensitizer in patients with dermatitis. Dermatitis. 2017 Nov/Dec;28(6):346-352. 6. As determined by a survey of US marketed drugs in Safety and Effectiveness of Consumer Antiseptic Rub Products; Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph, Docket No. FDA-2016-N-0124 *Based on intended use of multiple applications.

Spread pneumonia awareness with our free downloadable resources:

Product info

What the experts say